MetaCap

MiniMed Group (MMEDV) vs Vivos Therapeutics (VVOS)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Relative performance

MMEDV+2.07%VVOS-0.99%
+2%+1%-1%
Oct 7, 20261 yearOct 8, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MMEDV versus VVOS key metrics
MetricMMEDVVVOS
Share price$19.50$0.1493
Market cap—$5.02M
1-day change-1.02%-0.13%
EPS (TTM)—$-1.88
Dividend yield0.00%0.00%
Annual dividend—$0.00
52-week high$20.00$3.28
52-week low$18.50$0.129
Distance from 52-week high-2.50%-95.45%
Analyst consensus—none
Avg. price target upside—+1319.96%
Average volume2.40K12.57M
Shares outstanding—33.61M
Employees—268
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Vivos Therapeutics

VVOS stock →

Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.

Health Care · Medical/Dental Instruments · 268 employees

MMEDV vs VVOS FAQ

Are MiniMed Group and Vivos Therapeutics in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons